Pharmaceutical Industry Websites

The following sites are sponsored by the manufacturers of these pharmaceutical agents:

Posts Tagged ‘NOF’

The Bone Health Guidelines are Changing

June 11, 2017 @ 4:58 pm
posted by Dr Ginther

University of Wisconsin hosts biennially the Bare Bones of Osteoporosis Care Symposium.  This year the Wisconsin Bone Club followed the symposium.

Felicia Cosman, MD from Helen Hayes in New York was the guest speaker at both.  She expanded on the new thoughts and guidelines presented at NOF in April.  These were a complete change of approach from just a few years ago.

Treat to Target.  Anabolics first to build bone and then preserve with Antiresorptives.  Reconsider VFA for all first time DXA evaluations.

More detail about these in the weeks to come.

Jay Ginther, MD

 

National Osteoporosis Prevention Month

May 5, 2017 @ 10:40 pm
posted by Dr Ginther

May is National Osteoporosis Month.  That should be National Osteoporosis Prevention Month.  Or perhaps National Bone Health Optimization Month.

Click on the helpful link to National Osteoporosis Foundation to learn more.

Take Control Naturally by following the posts from earlier this year.  And get a Complete Bone Health Evaluation.

Jay Ginther, MD

“Treat to Target” and “Use VFA” in 2017

April 23, 2017 @ 8:50 pm
posted by Dr Ginther

Clinical Osteoporosis 2017, NOF and ISCD joint meeting had a different emphasis this year.  Fracture Risk, rather than Bone Mineral Density (BMD) is now the key metric.  Several speakers emphasizd the importance of VFA in making the diagnosis of Clinical Osteoporosis.  This is something I have presented in poster exhibits 2015, 2016 and 2017.  I am now mainstream!

“Treat to Target” was the big new message this year.  We should set a target of decreased Fracture Risk for each patient and alter treatment until we reach it.  This has been routine for years in diabetes, hypertension, cholesterol, etc.  This is recognition that Osteoporosis is a chronic disease that we can control, but never cure, just like many others.

Take Control Naturally is the necessary first step, as I have outlined over the last few months.  This is often sufficient for prevention and in mild disease.

Advanced Osteoporosis, especially after fragility fractures, or vertebral compression fractures seen on VFA, is usually beyond nutrition and exercise only.  This will usually require medications to significantly reduce fracture risk.

The huge change is the recommendation to use an Anabolic medication first, to markedly reduce fracture risk, when BMD is very low or multiple fractures have already occured.  Then follow up with an Antiresorptive to maintain a low fracture risk.  Traditionally Medicare and other insurances have demanded we try Antiresorptives first to maintain bone as it is, even when multiple fractures have proven the bone to NOT be good enough at curent BMD.

We are entering a new age of Fracture Prevention!!

Jay Ginther, MD

NOF & ISCD at “Clinical Osteoporosis 2017”

April 17, 2017 @ 5:24 pm
posted by Dr Ginther

The National Osteoporosis Foundation (NOF) and the International Society for Clinical Densitometry (ISCD) are meeting together later this week.  This will be my 10th attendance at each group.  They are both always interesting.

I will be presenting a new research project this year – “Vertebral Compression Deformities in Patients with Normal Bone Mineral Density”.

This is a further study of the 79 patients with Normal BMD by DXA alone, who were changed to Clinical Osteoporosis because of vertebral compression fractures found on VFA from last year’s study of 1259 consecutive patients with first-time VFA at our facility.

I look forward to seeing what else is new this year.

Jay Ginther, MD